Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome

Martin-Llahi, 2011, Prognostic importance of the cause of renal failure in patients with cirrhosis, Gastroenterology, 140, 488, 10.1053/j.gastro.2010.07.043 Martín-Llahí, 2008, Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study, Gastroenterology, 134, 1352, 10.1053/j.gastro.2008.02.024 Sanyal, 2008, A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome, Gastroenterology, 134, 1360, 10.1053/j.gastro.2008.02.014 Cavallin, 2015, Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial, Hepatology, 62, 567, 10.1002/hep.27709 Cavallin, 2016, Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study, Hepatology, 63, 983, 10.1002/hep.28396 Schrier, 1988, Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis, Hepatology, 8, 1151, 10.1002/hep.1840080532 Ruiz-del-Arbol, 2003, Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis, Hepatology, 38, 1210, 10.1053/jhep.2003.50447 Nazar, 2010, Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome, Hepatology, 51, 219, 10.1002/hep.23283 Boyer, 2011, Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics, J Hepatol, 55, 315, 10.1016/j.jhep.2010.11.020 Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 1426, 10.1053/j.gastro.2013.02.042 Bernardi, 2015, Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis, J Hepatol, 63, 1272, 10.1016/j.jhep.2015.07.004 Clària, 2016, Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure, Hepatology, 64, 1249, 10.1002/hep.28740 Rodríguez, 2014, Terlipressin and albumin for type 1 hepatorenal syndrome associated with sepsis, J Hepatol, 60, 955, 10.1016/j.jhep.2013.12.032 Salerno, 2007, Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis, Gut, 56, 1310 Jalan, 2014, Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure, J Hepatol, 61, 1038, 10.1016/j.jhep.2014.06.012 Fine, 1999, A proportional hazards model for the subdistribution of a competing risk, J Am Stat Assoc, 94, 496, 10.1080/01621459.1999.10474144 Angeli, 2013, Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites, Liver Int, 33, 16, 10.1111/j.1478-3231.2012.02807.x Angeli, 2015, Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites, J Hepatol, 62, 968, 10.1016/j.jhep.2014.12.029 Fickert, 2013, Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice, Hepatology, 58, 2059, 10.1002/hep.26599 Gómez, 2017, Metabolic reprogramming and tolerance during sepsis-induced AKI, Nat Rev Nephrol, 13, 143, 10.1038/nrneph.2016.186 Angeli, 2015, Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis, Gut, 64, 1616, 10.1136/gutjnl-2014-307526